ZartashGulMD

Oncology • Milwaukee, WI

Assistant Professor, Internal Medicine, University of Kentucky College of Medicine

Join to view full profile

Dr. Gul is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Gul's full profile

Already have an account?

Office
2900 W Oklahoma Ave
Milwaukee, WI 53215
Phone+1 414-649-6380

Fax+1 414-649-5389

Education & Training

Detroit Medical Center/Wayne State UniversityFellowship, Hematology and Medical Oncology, 2008 - 2011
Wayne State University School of MedicineResidency, Internal Medicine, 2005 - 2008
Dow University of Health SciencesClass of 2001

Certifications & Licensure

VA State Medical License 2023 - 2026
WI State Medical License 2020 - 2025
PA State Medical License 2023 - 2024
KY State Medical License 2011 - 2022
OH State Medical License 2016 - 2021
WV State Medical License 2018 - 2020
MI State Medical License 2005 - 2012
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) Start of enrollment: 2011 Oct 01
Recruiting
Double Cord Versus Haploidentical (BMT CTN 1101) Start of enrollment: 2012 Jun 01
Completed
Phase 3
Cytarabine and Daunorubicin Hydrochloride or Idarubicin and Cytarabine With or Without Vorinostat in Treating Younger Patients With Previously Untreated Acute Myeloid Leukemia Start of enrollment: 2013 Feb 12
Completed
Phase 3

Publications & Presentations

PubMed

Evaluation of Primary Oral Vancomycin Prophylaxis AgainstInfection During Autologous Stem Cell Transplantation.
Michael J Williams, Sol Atienza, Erin Franzen, Heena Rathod, Brittany Mejaki
Open Forum Infectious Diseases. 2024-11-01
Development of Subcutaneous Panniculitis-Like T-cell Lymphoma After Immune Checkpoint Inhibitor Treatment.
Tommy Y Yu, Zartash Gul, Alicia M Hunt, Michael J Williams, Alexander M Maley
Cureus. 2024-08-01
Comparison of intermittent intravenous tacrolimus to continuous tacrolimus in adult allogeneic stem cell transplant recipients.
Michael Williams, Zartash Gul, Justin Graff, Brittany Mejaki, Sherjeel Sana
Journal of Oncology Pharmacy Practice. 2024-05-05

Abstracts/Posters

Intravenous(IV) Busulfan Pharmacokinetics Using Busulfan And Fludarabine Conditioning In Instituions Where The Capability Of Doing Pharmacokinetics Is Not Present. Or...
Zartash Gul, MD, Shaily Arora, PharmD, Amber Lawson, PharmD, BCOP and Heidi L Weiss, Professor department of Biostatistics, ASBMT, 1/1/2014
Rabbit ATG results in improved lymphocyte count recovery compared to alemtuzumab after allogeneic transplant which predicts for better overall survival. abstract Nr. 775
Zartash Gul, Sam Bailey, Dianna Howard, Emily Van Meter, John Hayslip, Gregory Monohan, Kevin McDonagh, Zaid Alkadhimi, EBMT, 1/1/2013
A prospective phase II trial: the combination of tacrolimus and rabbit anti-thymocyte globulin (Thymoglobulin Thymo) to prevent acute graft-versus-host disease in pati...
Zaid Al-Kadhimi, Zartash Gul, Wei Chen, Daryn Smith, Muneer Abidi, Alice Mitchell, Abhinav Deol, Lawrence Lum, Lois Ayash, Voravit Ratanatharathorn, Joseph Uberti, EBMT, 1/1/2013
Cytarabine plus mitoxantrone versus cytarabine plus clofarabine as second-line therapy in AML. abstract Nr. 116833
Zartash Gul, Asheesh Jain, Stacey A. Slone, Ali, Raufi, Emily Marie Van Meter, Amber Lawson, John W. Hayslip, Gregory Monohan, Dianna S. Howard, Kevin T. McDonagh, Zai..., ASCO, 1/1/2013
Hypomethylating agents as first-line therapy in acute myeloid leukemia (AML). abstract Nr. 116538
Samuel D. Bailey, Zartash Gul, Stacey A. Slone, Emily Marie Van Meter, Amber Lawson, Ali Raufi, John W. Hayslip, Gregory Monohan, Dianna S. Howard, Kevin T. McDonagh, ..., ASCO, 1/1/2013
Lymphocyte Count Above 300x X 106/Ml 90 Days Post Transplant Predicts Better Overall Survival After Alemtuzumab for Unrelated Donor Stem Cell Transplant Abstract ID: 2...
Z.Gul, SD Bailey, E Van Meter, Z. Al-Kadhimi, A. Lawson, J. Hayslip, GP. Monohan, B. Shelton, KT. McDonagh, D. Howard, ASBMT, 1/1/2013
Lower Lymphocyte Count At Day 30 Predicts Worse Overall Survival with Tacrolimus and Mycophenolate Mofetil Use for GvHD Prophylaxis: A Large Retrospective Analysis. (P...
Z. Al-Kadhimi, Z. Gul, W. Chen, D Smith, A. Deol, M. H. Abidi, L. Ayash, L.G. Lum, V. Ratanatharathorn and J.P. Uberti, ASBMT, 1/1/2013
Phase II trial: The Combination of Tacrolimus, Sirolimus, and Rabbit Anti-Thymocyte Globulin (Thymoglobulin Thymo) (TST) to Prevent Acute Graft-vs-Host Disease (aGVHD)...
Z. Al-Kadhimi , Z. Gul, R. Rodriguez , W. Chen , A. Mitchell , M. Abidi ,L. Ayash, A. Deol , L. Lum , V. Ratanatharathorn , J. Uberti, ASBMT Poster, 1/1/2011
Early Lymphocyte Recovery Post Unrelated Hematopoietic Stem Cell Transplant (UHSCT) is Associated with Better Survival and Less Acute Graft Versus Host Disease (aGVHD)...
Z. Gul , I. Ditah, M. Abdul-Hussein , A. Deol , L. Ayash, M. Abidi , L. Lum , J. Uberti, V. Rratanatharathorn V. Rratanatharathorn, ASBMT Poster, 1/1/2011
A Phase I Study of Bortezomib During Maintenance Phase After High-Dose Melphalan and Autologous Stem Cell Transplantation In Patients with Multiple Myeloma. Poster Num...
MH. Abidi, Z Gul, LG. Lum, J Abrams, S Cronin, M Ventimiglia, A Deol, L Ayash, Z Al-Kadhimi, V Ratanatharathorn, JP. Uberti, ASH Annual Meeting, 1/1/2010
Comparison of Clinical Outcomes and Day 30 Lymphocyte Recovery Between Two aGVHD Prophylaxis Regimens In Matched Unrelated Hematopoietic Stem Cell Transplant (MUD) Pat...
Z. Gul, M. Abdul-Hussein, I Ditah, JP. Uberti, MH. Abidi, L Ayash, MG. Lum, V Ratanatharathorn, Z Al-Kadhimi, ASH Annual Meeting, 1/1/2010
The Combination of Tacrolimus (T), Sirolimus (S), and Rabbit Anti-Thymocyte Globulin (Thymoglobulin Thymo) to Prevent Acute Graft-Vs-Host Disease (aGVHD) in Patients (...
ZS Al-Kadhimi, Z Gul, LG. Lum, L Ayash, MH. Abidi, W Chen, A Mitchell, V Ratanatharathorn, J Uberti, Blood; ASH Annual Meeting, 1/1/2009
Prognostic Value of Low Platelets in MDS Patients with Del (5q).
N. Galili, A. Ahmed, F. Quddus, S. Jandani, Z. Gul, A.Siddiki, M. Mumtaz, M. Mehdi, D. Devuni, A. Raza, ASCO Annual Meeting Proceedings, 1/1/2007
Incidence of JAK2 Mutation in Patients with MDS and Myelofibrosis.
Z. Gul, ACP Oral Presentation, 1/1/2007
Incidence of FLT3 Mutation in AML Patients Transformed from a Prior MDS.
Z. Gul, ACP Oral Presentation, 1/1/2007
Autologous Stem Cell Transplantation for Elderly Patients with Multiple Myeloma.
M.H. Qazilbash , Z. Gul , S. Jindani , R. Saliba , C. Hosing , F. Mendoza , S.P. Qureshi, D.M. Weber , M. Wang , T. Flosser D.P. Couriel, M. De Lima P. Kebriaei, U. Po..., BBMT, 1/1/2007
Arsenic Trioxide with Ascorbic Acid and High-Dose Melphalan for Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma.
M.H. Qazilbash , S. Jindani , Z. Gul ,R. Saliba , C. Hosing , F. Mendoza S.P. Qureshi, D.M. Weber , M. Wang , T. Flosser D.P. Couriel, M. De Lima P. Kebriaei, U. Popat..., BBMT, 1/1/2007
Screening for Lung Cancer.
Z. Gul, ACP Poster Presentation, 1/1/2006
A Case of Myelodysplastic Syndrome, Refractory Anemia with Ringed Sideroblasts and Thrombocytosis.
Z. Gul, ACP Poster Presentation, 1/1/2006
High Rates of Severe aGVHD with Tacrolimus and Mycophenolate Mofetil in a Large Cohort of Related and Unrelated Allogeneic Transplant Patients. Abstract Poster ID 1951
Z. Al-Kadhimi, Z. Gul, W. Chen, D Smith, A. Deol, M. H. Abidi, L. Ayash, L.G. Lum, V. Ratanatharathorn and J.P. Uberti, ASH
EBMT Risk Score for Pre Transplant Risk Assessment in Patients with Multiple Myeloma. Poster ID 3094
Z. Gul, H. Khan, Q. Bashir, N. Shah, S. Parmar, Y.T. Dinh, C.M. Hosing, U.R. Popat, P. Kebriaei, P. Anderlini, E.J. Shpall, S. Giralt, R.E. Champlin and M.H. Qazilbash, ASH
Cardiac Toxicity After High-Dose Melphlan and Autologous Hematopoietic Stem Cell. Poster ID 2027
Z.Gul, Q. Bashir, Y. Nieto, N. Sherwani, S. Parmar, N. Shah, Y.T. Dinh, C.M. Hosing, U.R. Popat, P. Kebriaei, E.J. Shpall, S.A. Giralt, R.E. Champlin, M.H. Qazilbash, ASH
Join now to see all